Skip to main content

Want a detailed portfolio tracker?

Minerva Neurosciences (NERV) P/E (2014 - 2026)

Minerva Neurosciences (NERV) P/E from Jul 1, 2014 to Jun 3, 2026. The TTM Minerva Neurosciences (NERV) P/E is -0.49. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Minerva Neurosciences (NERV)

YearP/EChange
2026-0.49-17.73%
2025-0.60-100.69%
202486.31-901.52%
2023-10.77+640.19%
2022-1.45-73.48%
2021-5.49-101.62%
2020338.18-1199.14%
2019-30.77-26.26%
2018-41.72-3.86%
2017-43.40-52.94%
2016-92.22+108.03%
2015-44.33+281.96%
2014-11.61N/A

Comparison Minerva Neurosciences (NERV) P/E with competitors

Minerva Neurosciences (NERV) P/E is -0.49.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.35%
NBYStablecoin Development Corp0.10-120.80%
ENLVEnlivex Therapeutics Ltd0.15-130.56%
FGENFibroGen Inc0.24-148.84%
TRAWTraws Pharma Inc0.47-196.20%
FBIOFortress Biotech Inc0.71-243.65%
CHRSCoherus Biosciences Inc0.98-299.02%
ORMPOramed Pharmaceuticals Inc1.47-399.80%
AGENAgenus Inc2.05-516.80%
VIVSVivoSim Labs Inc2.54-615.95%
INVAInnoviva Inc3.19-748.76%
CRMDCorMedix Inc3.65-841.79%
ABEOAbeona Therapeutics Inc4.20-955.59%
VXRTVaxart Inc4.26-967.11%
CVACCureVac N.V.4.45-1004.55%
SRPTSarepta Therapeutics Inc4.62-1040.89%
GLPGGalapagos NV4.86-1088.63%
RIGLRigel Pharmaceuticals4.92-1100.98%
ZVRAZevra Therapeutics Inc4.97-1112.07%
ABUSArbutus Biopharma Corp5.69-1258.51%
CGENCompugen Ltd7.38-1602.42%
AUPHAurinia Pharmaceuticals Inc9.25-1982.41%
ACADAcadia Pharmaceuticals Inc9.59-2050.90%
OMEROmeros Corporation9.88-2111.01%
PLXProtalix BioTherapeutics Inc9.91-2116.24%
SPROSpero Therapeutics Inc10.73-2284.23%
ADMAAdma Biologics Inc11.33-2405.48%
SVASinovac Biotech Ltd11.44-2426.93%
TBPHTheravance Biopharma Inc11.78-2496.23%
HRMYHarmony Biosciences Holdings Inc12.18-2578.39%
TGTXTG Therapeutics Inc13.18-2781.67%
INCYIncyte Corp13.38-2822.89%
SABSSAB Biotherapeutics Inc14.06-2960.38%
XOMAXOMA Corp14.95-3140.96%
REGNRegeneron Pharmaceuticals Inc14.98-3148.09%
PBYIPuma Biotechnology Inc15.05-3162.37%
EXELExelixis Inc15.79-3313.84%
NAGENiagen Bioscience Inc16.35-3427.80%
CPRXCatalyst Pharmaceuticals Inc17.34-3629.20%
MDXGMimedx Group Inc17.38-3635.43%
ARGXArgen X SE23.07-4794.47%
HALOHalozyme Therapeutics Inc23.20-4820.72%
XOMAOXOMA Corp25.34-5257.01%
VRTXVertex Pharmaceuticals Inc25.66-5320.29%
XOMAPXOMA Corp25.67-5323.20%
CTMXCytomX Therapeutics Inc25.70-5328.86%
ASNDAscendis Pharma A/S26.35-5462.38%
RPRXRoyalty Pharma plc - Class A27.50-5694.60%
SLNOSoleno Therapeutics Inc29.02-6003.87%
LGNDLigand Pharmaceuticals Inc - Class B30.19-6242.18%
BMRNBiomarin Pharmaceutical Inc37.51-7731.76%
APLSApellis Pharmaceuticals Inc39.02-8039.80%
KRYSKrystal Biotech Inc39.70-8177.43%
GMABGenmab40.20-8280.39%
ONCBeiGene Ltd67.03-13738.26%
TECHBio-Techne Corp68.59-14057.33%
VCELVericel Corp80.63-16505.98%
PHARPharming Group N.V.87.74-17952.87%
ALNYAlnylam Pharmaceuticals Inc124.93-25520.80%
TLXTelix Pharmaceuticals Ltd139.89-28564.17%
CORTCorcept Therapeutics Inc158.39-32328.16%